CORTIAZEM RETARD

Modified-release tablet, 90 mg
RxActive license

Active substance (INN)

diltiazem

Pharmaceutical form

Pharmaceutical formModified-release tablet
Strength90 mg
PackagingUkupno 30 tableta sa modifikovanim oslobađanjem u blisteru (3x10) u kartonskoj kutiji
ManufacturerHemofarm a.d. Vršac, Serbia
Therapeutic groupCardiovascular system (C08DB01)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateJune 23, 2016

Analogs in Montenegro

1

Other medicines with the same active substance

Source: CInMED register